AlliedPath, Inc. is a leading cancer-focused molecular diagnostics testing laboratory which offers an extensive menu of high-quality, solid tumor specific tests. We partner with regional hospital and reference laboratories to provide test results which are combined with expert pathology analysis into an easy to interpret patient report for the oncologist.
The Company specializes exclusively in solid tumor testing, which is based on the genetic analysis of a patient’s tumor DNA, RNA, and proteins. The results provide relevant information for the physician to determine optimal treatment strategies, improving personalized medical care and enhancing quality of life for the patient.
Additionally, AlliedPath will serve the pharmaceutical industry by providing specialized molecular tests that are integral tools for predicting drug safety and efficacy.
AlliedPath's very own CEO Philip Ginsburg sits down with veteran broadcast journalist, David Wohl to discuss AlliedPath's analysis process for genetic mutation in tumors to tailor treatment to the individual's cancer. To view the video, click here.
AlliedPath will co-chair the National Lung Cancer Partnership's inaugural Free To Breathe® 5K Run/Walk in San Diego, CA on August 21st, 2010. For more information about the event, click here.